Company Profile

QT Medical Inc (AKA: Neovative)
Profile last edited on: 7/13/20      CAGE: 75G59      UEI: FLY3JASWB8M5

Business Identifier: Electrocardiogram (ECG)
Year Founded
2013
First Award
2015
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1360 Valley Vista Drive Suite 203
Diamond Bar, CA 91765
   (909) 323-0007
   marketing@qtmedical.com
   www.qtmedical.com
Location: Single
Congr. District: 39
County: Los Angeles

Public Profile

QT Medical, Inc. is a medical device startup aiming to make high quality 12-lead electrocardiogram (ECG) available to everyone. QT ECG™, the first product of QT Medical, is the world's most compact 12-lead ECG system. With its simplicity, ease of use, familiar interface by mobile technology, QT ECG™ is bringing hospital-quality 12-lead ECG to homes. It is optimized for high risk patients who just had coronary artery bypass graft (CABG) surgery, or percutaneous coronary intervention (PCI, i.e. coronary stent). It is also designed for home use by patients with chronic heart failure and arrhythmias. QT ECG™ is digital, wireless, and mobile friendly. It is smaller than a deck of cards, fits in the shirt pocket, and works with iOS and Android phones and tablets. The patented, proprietary electrodes can save up to 70% time in ECG procedures and greatly reduce errors related to electrode misplacement of and cable connecti

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 NIH $1,769,400
Project Title: Bluebox - a Complete Code Blue Data Recorder
2015 1 NIH $207,102
Project Title: Asthmagram: Objective Assessment of Asthma Symptoms in Children

Key People / Management

  Ruey-Kang Chang

Company News

There are no news available.